Uncategorized

NuVasive Forever Barred From Using NEUROVISION Trademark

Los Angeles, September 5, 2014 –

A Los Angeles federal judge issued a permanent injunction earlier this week against NuVasive, Inc. (NUVA), forever barring the medical device manufacturer from using the trademark NEUROVISION to promote or sell medical devices in the United States.

The injunction follows a verdict earlier this year in which a jury found that Ventura, California-based Neurovision Medical Products, Inc. is the rightful owner of the NEUROVISION trademark and that NuVasive had been willfully infringing upon Neurovision Medical’s trademark rights. The jury also found clear and convincing evidence that NuVasive had defrauded the United States Patent and Trademark Office by registering the NEUROVISION mark for itself despite knowing of Neurovision Medical’s superior rights in the mark. The jury awarded $30 million.

Following the verdict, the judge denied NuVasive’s post-trial motions and granted an injunction. In the judge’s written decision granting the injunction, she found that Neurovision Medical “would suffer irreparable harm absent an injunction” and added that she “has no confidence that in the absence of an injunction, [NuVasive] will stop using the mark.”

About Neurovision Medical:

Neurovision Medical is a surgical device company based in Ventura, California. It was founded in 1985 by Dr. J. Lee Rea, a physician and electrical engineer, who was a pioneer in the field of nerve location and avoidance technology used in surgery. Currently, Neurovision Medical is known for state-of-the-art nerve surveillance technology and continues to develop, market, and distribute such products throughout the United States and abroad. Further information about Neurovision Medical can be found at its website www.neurovisionmedical.com.

Contact

Any questions or comments about this press release should be directed to Neurovision Medical Products at (805) 477-0655 or contact@neurovisionmedical.com.

Order Granting Plaintiff Motion for Permanent Injuction

[gview file=”http://www.orthospinenews.com/wp-content/uploads/2014/09/481-Order-Granting-Plaintff_s-Motion-for-Permanent-Injunction.pdf” save=”1″]

Permanent Injunction Issued by Judge

[gview file=”http://www.orthospinenews.com/wp-content/uploads/2014/09/Permanent-Injunction-by-Judge-Fischer.pdf” save=”1″]
Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close